Lorenzo G. Quiambao

Lorenzo G. Quiambao

Auto-generated profile, based on publicly available information

Lorenzo G. Quiambao

Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA 92037, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 October 2020 in Science
Verified
Journal Article
Open access
PDF file
JMJose Mateus
Jose Mateus
AGAlba Grifoni
Alba Grifoni
Alison TarkeAlison Tarke
Alison Tarke
JSJohn Sidney
John Sidney
SRSydney I. Ramirez
Sydney I. Ramirez
DWDaniela Weiskopf
Daniela Weiskopf
Preexisting immune response to SARS-CoV-2: Robust T cell responses to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus occur in most individuals with coronavirus disease 2019 (COVID-19). Several studies have reported that some people who have not been exposed to SARS-CoV-2 have preexisting reactivity to SARS-CoV-2 sequences. The immunological mechanisms underlying this preexisting reactivity are not clear, but previous exposure to widely circulating common cold coronaviruses might be involved. Mateus et al. found that the preexisting reactivity against SARS-CoV-2 comes from memory T cells and that cross-reactive T cells can specifically recognize a SARS-CoV-2 epitope as well as the homologous epitope from a common cold coronavirus. These findings underline the importance of determining the impacts of preexisting immune memory in COVID-19 disease severity. Science , this issue p. 89

6 May 2016 in Journal of the American Chemical Society
Verified
Journal Article
Open access
SCSteven P. Cummings
Steven P. Cummings
TLThanh-Ngoc Le
Thanh-Ngoc Le
GFGilberto Enrique Fernandez
Gilberto Enrique Fernandez
LQLorenzo G. Quiambao
Lorenzo G. Quiambao
BSBenjamin J. Stokes
Benjamin J. Stokes
There are few examples of catalytic transfer hydrogenations of simple alkenes and alkynes that use water as the stoichiometric H or D atom donor. We have found that diboron reagents efficiently mediate the transfer of H or D atoms from water onto unsaturated C–C bonds using a palladium catalyst. This reaction can be conducted on a broad variety of alkenes and alkynes at ambient temperature, on gram scale, using dichloromethane or even water itself as the solvent. Mechanistic experiments suggest that this reaction is made possible by an unprecedented and rate-determining σ-bond metathesis event that generates a Pd–hydride intermediate. Critically, complete deuterium incorporation from stoichiometric D2O is possible.

1 January 2020 in Journal of Immunology Research
Verified
Journal Article
Open access
RARicardo da Silva Antunes
Ricardo da Silva Antunes
LQLorenzo G Quiambao
Lorenzo G Quiambao
ASAaron Sutherland
Aaron Sutherland
FSFerran Soldevila
Ferran Soldevila
Sandeep DhandaSandeep Dhanda
Sandeep Dhanda
ASAlessandro Sette
Alessandro Sette
The immune response elicited by the protective whole‐cell pertussis (wP) versus the less‐protective acellular pertussis (aP) vaccine has been well characterized; however, important clinical problems remain unsolved, as the inability of the currently administered aP vaccine is resulting in the reemergence of clinical disease (i.e., whooping cough). Strong evidence has shown that original, childhood aP and wP priming vaccines provide a long‐lasting imprint on the CD4+ T cells that impacts protective immunity. However, aP vaccination might prevent disease but not infection, which might also affect the breadth of responses to Bordetella pertussis (BP) antigens. Thus, characterizing and defining novel targets associated with T cell reactivity are of considerable interest. Here, we compare the T cell reactivity of original aP and wP priming for different antigens contained or not contained in the aP vaccine and define the basis of a full‐scale genomic map of memory T cell reactivity to BP antigens in humans. Our data show that the original priming after birth with aP vaccines has higher T cell reactivity than originally expected against a variety of BP antigens and that the genome‐wide mapping of BP using an ex vivo screening methodology is feasible, unbiased, and reproducible. This could provide invaluable knowledge towards the direction of a new and improved pertussis vaccine design.